2 hrs ago
FSSAI Files Three Cases Against Nestlé India Infant Products
India’s food regulator examined three Nestlé India infant nutrition products and their online promotions.
It said NAN Excella Pro Stage 1 used claims about “5 HMOs” and Whey Protein.
It also said Lactogen Pro 1 described Whey Protein as easy to digest.
The regulator said these promotional claims broke rules for advertising infant foods.
A separate follow-up formula sample had less biotin than required.
Another laboratory checked the sample and found the same problem.
FSSAI therefore filed three cases against Nestlé India.
The company’s shares fell by about 2% to 3% that day.
FSSAI filed three separate adjudication cases against Nestlé India over three infant nutrition products.
The regulator flagged “5 HMOs” and “Whey Protein” claims on NAN Excella Pro Stage 1.
Lactogen Pro 1 carried a claim describing its Whey Protein as easy to digest.
A follow-up formula sample failed prescribed biotin requirements in both initial and referral laboratory analyses.
Nestlé India shares fell roughly 2% to 3% on September 18, 2026.
- Who
- The Food Safety and Standards Authority of India (FSSAI) and Nestlé India Limited.
- What
- FSSAI filed three adjudication cases over promotional claims on two products and non-compliant biotin levels in a follow-up formula.
- Where
- The promotional material was available on e-commerce platforms in India; the share reaction was reported on Indian exchanges.
- When
- The action and reported share-price decline occurred on September 18, 2026.
- Why
- FSSAI said the promotional claims violated infant-food advertising restrictions and the follow-up formula failed prescribed biotin requirements.
Key facts
- Regulator
- Food Safety and Standards Authority of India (FSSAI)
- Company
- Nestlé India Limited
- Products
- NAN Excella Pro Stage 1, Lactogen Pro 1, and a follow-up formula
- Claims flagged
- “5 HMOs” and “Whey Protein” for NAN Excella Pro Stage 1; easy-to-digest Whey Protein for Lactogen Pro 1
- Rules cited
- Regulation 4(2) of the Food Safety and Standards (Foods for Infant Nutrition) Regulations, 2020, and Section 3 of the Infant Milk Substitutes, Feeding Bottles and Infant Foods Act, 1992
- Laboratory finding
- The follow-up formula did not meet prescribed biotin requirements in initial and referral analyses
- Market reaction
- Nestlé India shares were reported down approximately 2% to 3%, with reports citing prices between ₹1,332.80 and ₹1,345.45
Quotes
Food Safety and Standards Authority of India (FSSAI)
India’s food safety regulator
“In NAN Excella Pro Stage 1, claims relating to "5 HMOs" and "Whey Protein" were observed, while in Lactogen Pro 1, a claim relating to "Whey Protein" being easy to digest was observed.”
livemint.com
freepressjournal.in
news18.com
“In view of the above contraventions, three separate adjudication cases have been filed against Nestlé India in respect of the three products.”
news18.com
firstpost.com
Sources
Nestle India share price falls 3%: FSSAI takes legal action over 3 baby products
FSSAI Files Cases Against Nestle India Over Infant Nutrition Products; Shares Fall 2%
FSSAI Action Against Nestle India: Infant Nutrition Products Under Scanner; Shares Fall 2%
FSSAI initiates legal action against Nestle India over non-compliant baby food products
FSSAI initiates legal action against Nestle India over three infant nutrition products, shares fall 2%
Food Authority Files 3 Cases Against Nestle India Over Infant Formula Products
FSSAI Initiates Legal Action Against Nestle India Over Infant Nutrition Products
Related news
FSSAI seizes misbranded infant food from Bengaluru company
FSSAI Action Prompts Bournvita and Amway to Drop Misleading Claims
FSSAI Cracks Down as Bournvita Withdraws Health Claims
FSSAI Notices Prompt Food Firms to Withdraw Misleading Claims
FSSAI Notices Push Food Firms to Withdraw Misleading Claims
Nestlé CEO Supports India Crackdown on Misleading Food Labels
FSSAI Flags Nestlé Infant Product Over Biotin Compliance
Food regulator weighs nationwide ban on analogue paneer
FSSAI Expands Dabur Crackdown, Orders Audit of 27 Lines
FSSAI Considers Nationwide Ban on Analogue Paneer After State Consultation
